MissionIR Articles
-
BlueSky AI Inc. (BSAI) Advances Modular Data Center Strategy with New Partnership
In a decisive move addressing the surging AI compute demand, BlueSky AI (OTC: BSAI) has selected Data Specialties Inc. (“DSI”) as the official provider for its premanufactured modular data centers, a strategic step reinforcing the company’s…
-
MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) CEO Featured on IBN’s GotStocks Podcast to Discuss Scalable AI Infrastructure Strategy
BluSky AI (OTC: BSAI) CEO Trent D’Ambrosio was featured on the latest episode of IBN’s GotStocks Podcast, where he outlined the company’s mission to deliver modular, high-performance AI infrastructure with dramatically shortened build times. D’Ambrosio…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Reports Strong Expectations for Quantum Computing-Based Optimization
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, released findings from a survey conducted with Wakefield Research showing rising enterprise interest in quantum optimization. The survey polled 400 business…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2025 Innovation Award for Remote Cardiac Diagnostics
HeartBeam (NASDAQ: BEAT), a medical technology company advancing personalized cardiac care, has received the Innovation Award in Remote Cardiac Diagnostics from the 2025 Medical Device Network Excellence Awards. The honor recognizes HeartBeam’s FDA-cleared 3D ECG…
-
Safe Pro Group Inc. (NASDAQ: SPAI) Earns Buy Rating, $8 Price Target from Litchfield Hills
Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, has received a Buy rating from Litchfield Hills Research upon coverage initiation on July 17, with the firm setting an…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Secures EU Patent for AI-Designed Cancer Drug LP-284
Lantern Pharma (NASDAQ: LTRN) announced the European Patent Office has issued a notice of allowance for a composition of matter patent covering LP-284, a clinical-stage drug candidate for relapsed or refractory non-Hodgkin’s lymphoma. The patent,…
-
MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Integrates AI Object Detection with U.S. Army Recon Drones
Safe Pro Group (NASDAQ: SPAI) has integrated its patented AI object detection models into drone platforms selected for the U.S. Army’s Short Range Reconnaissance Program of Record, aiming to enhance explosive threat detection and ISR…
-
MissionIRNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Leveraging Crypto to Bridge New World and Classic Industry
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada…
-
MissionIRNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Charts Dual-Path for NRX-100
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is accelerating its push toward regulatory approval of NRX-100, a preservative-free intravenous ketamine formulation. “The company recently filed an…
-
D-Wave Quantum Inc. (NYSE: QBTS) Secures $400 Million in Equity Offering, Eyes Acquisitions and Expansion
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has completed sales of $400 million in gross proceeds of its common stock in an at-the-market equity (“ATM”) offering, a move…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sets Key Dates for 25% Preferred Stock Dividend
Nutriband (NASDAQ: NTRB) is reminding shareholders of its upcoming 25% preferred stock dividend. Shareholders of record as of July 25, 2025, will receive one preferred share for every four common shares held, with the dividend…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharma company focused on treating brain and CNS cancers, will implement a 1-for-12 reverse stock split effective July 22, 2025. Its common stock will continue trading under the symbol CNSP…
-
Soligenix Inc. (NASDAQ: SNGX) Reports Strong Results in ‘Real-World’ Trial
Soligenix (NASDAQ: SNGX) is reporting encouraging interim outcomes from the ongoing investigator-initiated study (“IIS”) of its HyBryte(TM) (synthetic hypericin) program, under the direction of Ellen Kim, MD, director of the Penn Cutaneous Lymphoma Program. Kim is…
-
Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Key Part of Five-Step Blueprint for a Balanced Rare-Earth Supply Chain
The tariff war between the United States and other countries, particularly China, has created a greater awareness of the tenuous U.S. position in terms of its reliance on China for essential materials for key products.…
-
MissionIRNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is executing a dual growth strategy focused on expanding its national network of mental health clinics through its subsidiary, HOPE Therapeutics, and advancing its proprietary NMDA-based therapies…
Search Articles
Latest Articles
- MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
- MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and Department of Commerce Sign Letter of Intent for $100 Million in CHIPS and Science Act Funding to Accelerate U.S. Leadership in Quantum Computing
- The Untapped Potential of Greenland’s Jameson Land Basin Creates Major Opportunity for Greenland Energy Company (NASDAQ: GLND)
- Regentis Biomaterials Ltd. (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair
- MissionIRNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Conducts First U.S. Live DefendAir Counter-Drone Demonstration